The medical device sector in Brazil faces a scenario of high relevance and natural vocation. There are structural, demographic, and regulatory factors that make the country a strategic target for international manufacturers seeking to expand their operations in Latin America.
A Robust and Expanding Market
According to Fortune Business Insights consulting firm, Brazil’s medical device market was valued at US$ 15.28 billion in 2024, with projections to grow to US$ 25.00 billion by 2032, corresponding to a CAGR (compound annual growth rate) of 6.4% between 2025 and 2032.
This growth is driven by demographic changes (such as population aging and increased chronic diseases), by the growing demand for diagnostics, medical interventions, and more sophisticated health solutions, factors that elevate the demand for medical devices.
Furthermore, the national health market combines a broad public structure with a significant private sector. According to recent surveys, the country has approximately 7,309 hospitals, of which about 63% are private.
Comprehensive Healthcare System and National Market Role
The Unified Health System (SUS) continues to play a central role: according to government data compiled for the international market, SUS is the sole healthcare provider for about 72% of the Brazilian population, that is, for the vast majority of citizens, in this indicator, approximately 164 million people.
This degree of coverage and the size of the hospital network create an environment of continuous demand for medical devices, considering use in both public and private hospitals, clinics, diagnostic centers, and laboratories.
Moreover, according to a study by the Netherlands Enterprise Agency, via the “Brazil Life Sciences & Health Market Study 2019” report, Brazil is recognized as the main medical device market in Latin America.
Why Brazil Represents a Strategic Opportunity for International Manufacturers
Demand scale: with thousands of hospitals and broad public health system coverage, there is a large domestic market that absorbs medical devices to meet diverse needs, from large hospitals to smaller clinics and units.
Public-private mix: the coexistence between public health (via SUS) and the private sector expands the range of opportunities, both for mass-market devices and cutting-edge technologies.
Consistent growth: the projected market from US$ 15.28 billion to US$ 25.00 billion indicates there is room for expansion in the coming years, especially considering technological innovations, population aging, and demands for more sophisticated healthcare.
Structured regulatory environment: although regulation (via Anvisa and other agencies) imposes important technical and regulatory requirements, which requires specialized workforce or local partnership, this environment also ensures clarity and predictability for those planning to enter the market with compliance and strategy.
Conclusion: Brazil as a Strategic Destination and Gateway
For international manufacturers, Brazil is not just another market, it is a strategic hub in Latin America: with favorable demographics, broad health infrastructure, real demand, and multiple channels (private + public). Among risks and regulatory complexity, there is also the advantage of operating in a large, consolidated environment with sustained growth opportunity.
For those who understand Brazilian regulation, taxes, logistics, and market particularities, the opportunity to enter the country represents more than sales, it represents real impact on health, access, and innovation. In these cases, relying on specialized medical device consulting or a partner region becomes essential.
If you seek to enter Brazil with medical devices, it is worth considering, with caution and strategy, that market conditions are solid and that the investment can be more than justified.
Find out more about BPO in RA!
*Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br
